A study of neurokinins and other oedema-inducing mediators and mechanisms in thermal injury

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 11, 1997, Pages 861-863

  Waller, J ^a   Siney, L ^a   Hoult, J R S ^a   Brain, S D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Dorsal rat skin; Neutrophils; Plasma extravasatin; Substance P; Thermal injury

Indexed keywords

BRADYKININ B2 RECEPTOR ANTAGONIST; GRANULOCYTE ANTIBODY; ICATIBANT; INDOMETACIN; NEUROKININ; NOLPITANTIUM; PROSTAGLANDIN SYNTHASE INHIBITOR; TACHYKININ RECEPTOR ANTAGONIST;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURN; CONTROLLED STUDY; EDEMA; EXTRAVASATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ACTIVATION; MALE; NONHUMAN; RAT; THERMAL INJURY;

EID: 0030823364     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb02705.x     Document Type: Article

References (11)

1. Starr MS, West GB. Bradykinin and oedema formation in heated paws of rats. Br. J. Pharmacol. Chemother. 1967; 31: 178-87.
2. 2 in leg lymph of rabbits after scalding injury. Acta Physiol. Scand. 1979; 107: 377-84.
3. Saria A. Substance P in sensory nerve fibres contributes to the development of oedema in rat hind paw after thermal injury. Br. J. Pharmacol. 1984; 82: 217-22.
4. Jonsson CE, Brodin E, Dalsgaard CJ, Haegerstrand A. Release of substance P-like immunoreactivity in dog paw lymph after scalding injury. Acta Physiol. Scand. 1986; 126: 21-4.
5. Siney L, Brain SD. Involvement of sensory neuropeptides in the development of plasma extravasation in rat dorsal skin following thermal injury. Br. J. Pharmacol. 1996; 117: 1065-70.
6. 1 receptor antagonist. Eur. J. Pharmacol. 1993; 250: 403-13.
7. Hock FJ, Wirth K, Albus U et al. HOE 140 a new potent and long acting bradykinin-antagonist: In vitro studies. Br. J. Pharmacol. 1991; 102: 769-73.
8. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971; 231: 232-5.
9. Schierwagen C, Bylund Fellenius AC, Lundberg C. Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J. Pharmacol. Methods 1990; 23: 179-86.
10. Bucky LP, Vedder NB, Hong HZ et al. Reduction of burn injury by inhibiting CD18-mediated leukocyte adherence in rabbits. Plast. Reconstr. Surg. 1994; 93: 1473-80.
11. Wedmore CV, Williams TJ. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature 1981; 289: 646-50.